Skip to content

Declaration on Corporate Governance

The Management Board and the Supervisory Board of Fresenius Medical Care are committed to responsible management that is focused on achieving a sustainable increase in the value of the Company. The implementation of long-term strategies, solid financial management, strict adherence to legal and ethical business standards, successful sustainability management to create lasting economic, ecological and social value, and a transparent communication of the Company are its key elements.

The Management Board and the Supervisory Board of Fresenius Medical Care AG (Company) report below on the fiscal year 2023 (the year under review) pursuant to Sections 289f, 315d of the German Commercial Code (Handelsgesetzbuch – HGB) and in accordance with principle 23 of the German Corporate Governance Code in the version dated April 28, 2022 (GCGC), as published in the German Federal Gazette (Bundesanzeiger) on June 27, 2022, on the Company’s corporate governance (Unternehmensführung) and also comment on recommendations and suggestions of the GCGC.

Declaration on Corporate Governance 2023

Archive

Declaration on Corporate Governance 2022
Declaration on Corporate Governance 2021
Declaration on Corporate Governance 2020
Declaration on Corporate Governance 2019
Declaration on Corporate Governance 2018
Declaration on Corporate Governance 2017
Declaration on Corporate Governance 2016
Contact us for further information
+49 6172 609 2525
Contact Investor Relations
Related content

Management Board

Our Management Board currently consists of five members. The international composition and the varied responsibilities reflect our global operations.

Fresenius Medical Care Declaration of Compliance

Declaration of Compliance

Fresenius Medical Care endorses the principles set forth in the German Corporate Governance Code.